Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 0.28% for the current model date.
BlackTreeCVE IntelligenceMesalvo · Meona Client Launcher Component
High technical severity; prioritise exposed affected systems while verifying vendor guidance.
High technical severity; prioritise exposed affected systems while verifying vendor guidance.
Fix not verifiedVendor disputed record. The reported behaviour is documented administrative functionality restricted to dedicated administrative permissions assigned by the operating hospital; its use by a permission holder is not a vulnerability. Unauthorised access to the functions is addressed under CVE-2026-0856. Improper Control of Generation of Code ('Code Injection') vulnerability in Mesalvo Meona Client Launcher Component, Mesalvo Meona Server Component enables code execution on other users' systems. This issue affects Meona Client Launcher Component: through 19.06.2020 15:11:49; Meona Server Component: through 2025.04 5+323020.
Vendor disputed record. The reported behaviour is documented administrative functionality restricted to dedicated administrative permissions assigned by the operating hospital; its use by a permission holder is not a vulnerability. Unauthorised access to the functions is addressed under CVE-2026-0856. Improper Control of Generation of Code ('Code Injection') vulnerability in Mesalvo Meona Client Launcher Component, Mesalvo Meona Server Component enables code execution on other users' systems. This issue affects Meona Client Launcher Component: through 19.06.2020 15:11:49; Meona Server Component: through 2025.04 5+323020.
Untrusted data can cross into a code-evaluation path and be interpreted as executable instructions.
An attacker operating through an adjacent network may attempt exploitation with elevated privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
Vendor disputed record. The reported behaviour is documented administrative functionality restricted to dedicated administrative permissions assigned by the operating hospital; its use by a permission holder is not a vulnerability. Unauthorised access to the functions is addressed under CVE-2026-0856. Improper Control of Generation of Code ('Code Injection') vulnerability in Mesalvo Meona Client Launcher Component, Mesalvo Meona Server Component enables code execution on other users' systems. This issue affects Meona Client Launcher Component: through 19.06.2020 15:11:49; Meona Server Component: through 2025.04 5+323020.
Untrusted data can cross into a code-evaluation path and be interpreted as executable instructions.
An attacker operating through an adjacent network may attempt exploitation with elevated privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-94: Improper Control of Generation of Code ('Code Injection'). The product constructs all or part of a code segment using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the syntax or behavior of the intended code segment.
CVSS:3.1/AV:A/AC:L/PR:H/UI:R/S:C/C:H/I:H/A:HCommon Vulnerability Scoring System 3.1: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 20 May 2026 · Last source change 1 Oct 2026, 19:31 UTC · CWE-94 · Improper Control of Generation of Code ('Code Injection')
Core structured fields are present and their contributing authorities are shown above.